Xoran Technologies announces the company’s recent submission of a U.S. FDA 510(k) application for TRON™, an open-bore fluoroscopy CT for full-body, point-of-care imaging. The potential new addition to Xoran’s suite of imaging systems offers potential benefits which include reduced transport risks to patients, improved accessibility to patient CT scans in limited spaces, and improved throughput for radiology departments.
With more than 20 patents, this FDA 510(k) submission builds on the company’s research and development efforts for lung CT imaging. Those research efforts have shown capability in point-of-care CT solutions for the neuro intensive care unit, the operating room, and satellite stations. Moreover, the mobile design and engineering of TRON marks a milestone toward optimizing a CT scanner and a point-of-care solution for patients beyond the designated confines of a limited space.
“This addition solidifies our commitment to improving patient accessibility to imaging at the point of care,” says Xoran CEO Misha Rakic. “The benefits of truly mobile compact devices cannot be underscored, and now by engineering the success of our head CT systems into an open-bore system, we are able to drive a new generation of Xoran’s point-of-care imaging devices.”